Compagnie Lombard Odier SCmA’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-44,500
Closed -$724K – 461
2024
Q1
$724K Sell
44,500
-5,000
-10% -$78.2K 0.01% 172
2023
Q4
$738K Hold
49,500
– – 0.01% 191
2023
Q3
$556K Hold
49,500
– – 0.01% 181
2023
Q2
$498K Buy
+49,500
New +$459K 0.01% 176

Other funds holding ELAN

Compagnie Lombard Odier SCmA's ELAN Position: Q2 2024 in Review

Compagnie Lombard Odier SCmA sold out of Elanco Animal Health (ELAN) in Q2 2024, closing a stake of 44,500 shares — an estimated $724K sold.

Compagnie Lombard Odier SCmA first reported a position in ELAN in Q2 2023 and held it in 4 quarters. The position peaked at $738K in Q4 2023. 402 funds tracked by Wall St. Rank hold ELAN as of Q2 2024.

  • Compagnie Lombard Odier SCmA reported no remaining Elanco Animal Health position as of Q2 2024 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 44,500 Elanco Animal Health shares in Q2 2024, an estimated $724K.
  • Compagnie Lombard Odier SCmA first reported a position in Elanco Animal Health in Q2 2023 and held it in 4 quarters.
  • Compagnie Lombard Odier SCmA's Elanco Animal Health position peaked at $738K in Q4 2023.
  • 402 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2024.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2024, filed 18 Jul 2024.